Articles Vol. 66 No. CĐ7-HNKH Bệnh viện K 22/05/2025

10. REVIEW OF QUALITY OF LIFE OF BONE METASTATIC PROSTATE CANCER PATIENTS AFTER ORCHIECTOMY AT K HOSPITAL IN 2023

Do Anh Tuan1,2, Le Thi Nga1,2, Chu Thi Ngoc Diep1,2, Le Viet1,2
1 Department of Urology Surgery – Vietnam National Cancer Hospital
2 Khoa Ngoại Tiết Niệu- Bệnh viện K
Corresponding author: lenga2612hmu@gmail.com
DOI: 10.52163/yhc.v66iCD7.2389
19 Views
18 Downloads
Keywords
Prostate cancer bone metastasis orchiectomy quality of life SF-36 UCLA-PCI
Abstract

Objective: To evaluate the quality of life (QoL) of patients before and after orchiectomy for prostate cancer (PC) with bone metastases at K Hospital in 2023.

Subjects and methods: Cross-sectional descriptive study of 70 PC patients with bone metastases underwent orchiectomy at K Hospital.

Results: The average age of patients was 67.8 ± 7.8 years old. The patient's pain intensity significantly decreased after surgery. The average scores of QoL domains according to the SF-36 and UCLA-PCI scales ranged from 82±9.77 to 95±10.93, corresponding to good QoL. In particular, the average score of sexual function was always at a very poor level after surgery.

Conclusion: The QoL of PC patients with bone metastases after orchiectomy was assessed at a good level.

References
[1]
Global Burden of Disease Cancer, C., et al. (2017).Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015:A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 3(4): 524-548 Google Scholar
[2]
Sung H, Ferlay J, Siegel RL, Laversanne M, et al. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin.71(3):209-249. [PubMed] [Reference list] Google Scholar
[3]
US Preventive Services Task Force. Grossman DC, Curry SJ, Owens DK, et al. (2018). Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 319(18):1901-1913 Google Scholar
[4]
https://gco.iarc.fr/today/data/factsheets/populations/704-viet-nam-fact-sheets.pdf Google Scholar
[5]
Gravis G., et al. (2016). Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial. Eur Urol,. 70(2): 256-62. Google Scholar
[6]
Tâm LTK, cộng sự (2020). Đánh giá kết quả điều trị nội tiết ung thư tuyến tiền liệt giai đoạn IV. Luận án tiến sỹ y học 2020. Google Scholar
[7]
Porreca A, Noale M, Artibani W, et al. (2018). Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study. Health Qual Life Outcomes.16:122. Google Scholar
[8]
Gaither TW, Kwan L, Villatoro J, Litwin MS (2022). Quality of life in low-income men after surgical castration for metastatic prostate cancer. Urol Oncol. 40(7):343.e7-343.e14. Google Scholar